Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008 Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD, David M. Cutler, PhD, Allison B. Rosen, MD, MPH, ScD The American Journal of Medicine Volume 127, Issue 7, Pages 608-615 (July 2014) DOI: 10.1016/j.amjmed.2014.03.017 Copyright © 2014 Elsevier Inc. Terms and Conditions
Figure 1 Age-adjusted incidence of ischemic and hemorrhagic stroke in the US Medicare population from 1988 to 2008. The American Journal of Medicine 2014 127, 608-615DOI: (10.1016/j.amjmed.2014.03.017) Copyright © 2014 Elsevier Inc. Terms and Conditions
Figure 2 Risk-adjusted 30-day mortality rates after hospitalization for ischemic or hemorrhagic stroke from 1988 to 2008 in a 20% sample of Medicare patients, adjusted for age, region, race, acute/prior myocardial infarction, congestive heart failure, vascular disease, pulmonary disease, dementia, paralysis, diabetes, renal disease, liver disease, ulcer disease, rheumatologic disease, and cancer. The American Journal of Medicine 2014 127, 608-615DOI: (10.1016/j.amjmed.2014.03.017) Copyright © 2014 Elsevier Inc. Terms and Conditions
Figure 3 Prevalence of medications used to prevent stroke among 138,821 participants aged ≥65 years in the MCBS (1992-2008). The American Journal of Medicine 2014 127, 608-615DOI: (10.1016/j.amjmed.2014.03.017) Copyright © 2014 Elsevier Inc. Terms and Conditions